Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma

NCT00019383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: sargramostim
BIOLOGICAL: tyrosinase peptide
BIOLOGICAL: tyrosinase-related protein-1

Sponsor

National Cancer Institute (NCI)